Health
Moderna Announces New Drug Application Submitted to Import and Distribute Moderna’s COVID-19 Vaccine Candidate in Japan – ACROFAN USA
50 million doses of Moderna’s COVID-19 vaccine candidate expected to be distributed beginning in the first half of 2021, pending licensure in JapanCAMBRIDGE, Mass.–(BUSINESS…
50 million doses of Modernas COVID-19 vaccine candidate expected to be distributed beginning in the first half of 2021, pending licensure in Japan
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Takeda Pharmaceutical Co., Ltd (NYSE: TAK) submitted a New Drug Application to the Government of Japans Ministry of Health, Labour and Welfare (MHLW) to import and distribute Modernas…
Continue Reading
